Victory Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-74,297
| Closed | -$74.2K | – | 2727 |
|
|
2022
Q4 | $74.2K | Sell |
74,297
-9,945
| -12% | -$9.93K | ﹤0.01% | 2402 |
|
|
2022
Q3 | $152K | Sell |
84,242
-1,585
| -2% | -$2.86K | ﹤0.01% | 2404 |
|
|
2022
Q2 | $249K | Buy |
85,827
+1,035
| +1% | +$3K | ﹤0.01% | 2284 |
|
|
2022
Q1 | $181K | Buy |
84,792
+385
| +0.5% | +$822 | ﹤0.01% | 2423 |
|
|
2021
Q4 | $393K | Sell |
84,407
-13,006
| -13% | -$60.6K | ﹤0.01% | 2288 |
|
|
2021
Q3 | $829K | Sell |
97,413
-42,327
| -30% | -$360K | ﹤0.01% | 1939 |
|
|
2021
Q2 | $2.29M | Sell |
139,740
-1,091,660
| -89% | -$17.9M | ﹤0.01% | 1592 |
|
|
2021
Q1 | $27.2M | Buy |
1,231,400
+1,022,384
| +489% | +$22.6M | 0.03% | 791 |
|
|
2020
Q4 | $6.47M | Buy |
209,016
+71,251
| +52% | +$2.2M | 0.01% | 1178 |
|
|
2020
Q3 | $2.8M | Buy |
137,765
+54,266
| +65% | +$1.1M | ﹤0.01% | 1345 |
|
|
2020
Q2 | $1.28M | Sell |
83,499
-84,983
| -50% | -$1.31M | ﹤0.01% | 1609 |
|
|
2020
Q1 | $1.3M | Buy |
168,482
+82,050
| +95% | +$635K | ﹤0.01% | 1760 |
|
|
2019
Q4 | $1.23M | Buy |
86,432
+73,578
| +572% | +$1.05M | ﹤0.01% | 1676 |
|
|
2019
Q3 | $193K | Buy |
12,854
+1,854
| +17% | +$27.8K | ﹤0.01% | 2232 |
|
|
2019
Q2 | $157K | Hold |
11,000
| – | – | ﹤0.01% | 1474 |
|
|
2019
Q1 | $192K | Buy |
+11,000
| New | +$192K | ﹤0.01% | 1578 |
|